Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 1/2 1

Status

Recruiting 37Unknown 14Active not recruiting 10Not yet recruiting 5Withdrawn 2Terminated 2Completed 1

Sponsor Class

OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Lymphoid 5Plasma cell 2Other hematologic neoplasm 1Gastrointestinal 1

Conditions

Lymphoma 2Burkitt Lymphoma 2Recurrence 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1Leukemia 1

Interventions

Cyclophosphamide 30Rituximab 23zanubrutinib 18fludarabine 14Vincristine 14venetoclax 13Prednisone 13blinatumomab 12Magnetic Resonance Spectroscopy 12Specimen Handling 11Doxorubicin 11obinutuzumab 10Bendamustine Hydrochloride 10Lenalidomide 9Dexamethasone 8polatuzumab vedotin 7glofitamab 7Methotrexate 7Radiotherapy 6Prednisolone 6N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 6Cytarabine 6Biopsy 6pirtobrutinib 5pegaspargase 5Immunotherapy, Adoptive 5tislelizumab 4tafasitamab 4selinexor 4orelabrutinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × Immunotherapy, Adoptive × Lymphoid × Clear all
NCT07463781 2026-03-13

NEURO_CAR-T

Fondazione Italiana Linfomi - ETS

Not yet recruiting
100 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT07043218 2025-06-29

A Clinical Study Exploring Universal CAR-T Cell in Patients With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Shanghai Tongji Hospital, Tongji University School of Medicine

Phase 1 Not yet recruiting
36 enrolled
Lymphoid

Burkitt Lymphoma

NCT07032324 2025-06-23

CT1190B

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 1 Not yet recruiting
27 enrolled
Lymphoid

Lymphoma, B-Cell

NCT07020260 2025-06-13

PACMAN

Princess Maxima Center for Pediatric Oncology

Phase 1/2 Not yet recruiting
18 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Lymphoma

NCT06647329 2024-10-17

CAR-T Therapy

Zhengzhou University

Phase 1 Not yet recruiting
30 enrolled
Lymphoid

Lymphoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡